 Connection
Kristin Mekeel to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Kristin Mekeel has written about Carcinoma, Hepatocellular.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.063 |
|
|
|
-
Hemming AW, Berumen J, Mekeel K. Hepatitis B and Hepatocellular Carcinoma. Clin Liver Dis. 2016 11; 20(4):703-720.
Score: 0.446
-
Anderson JE, Hemming AW, Chang DC, Talamini MA, Mekeel KL. Are hepatocellular carcinoma patients more likely to receive liver resection in regions with longer transplant wait times? Transplant Proc. 2014 Jan-Feb; 46(1):199-201.
Score: 0.372
-
Schnickel GT, Fabbri K, Hosseini M, Misel M, Berumen J, Parekh J, Mekeel K, Dehghan Y, Kono Y, Ajmera V. Liver transplantation for hepatocellular carcinoma following checkpoint inhibitor therapy with nivolumab. Am J Transplant. 2022 06; 22(6):1699-1704.
Score: 0.163
-
Kim RD, Reed AI, Fujita S, Foley DP, Mekeel KL, Hemming AW. Consensus and controversy in the management of hepatocellular carcinoma. J Am Coll Surg. 2007 Jul; 205(1):108-23.
Score: 0.059
-
Hemming AW, Mekeel KL, Zendejas I, Kim RD, Sicklick JK, Reed AI. Resection of the liver and inferior vena cava for hepatic malignancy. J Am Coll Surg. 2013 Jul; 217(1):115-24; discussion 124-5.
Score: 0.022
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|